×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Pharma Co. Impel's Ch. 11 Liquidation Plan Approved
Law360
Migraine-drug maker Impel Pharmaceuticals received confirmation of its Chapter 11 liquidation plan on Monday after selling its assets and...
1 month ago
One Impel NeuroPharma, Inc. (NASDAQ:IMPL) insider upped their stake in the previous year
Yahoo Life UK
From what we can see, insiders were net buyers in Impel NeuroPharma, Inc.'s ( NASDAQ:IMPL ) during the past 12 months...
3 weeks ago
Pharma Co. Impel Hits Ch. 11 With $127M Debt And Sale Plans
Law360
Migraine-drug maker Impel Pharmaceuticals Inc. and one of its subsidiaries filed for bankruptcy in Texas, listing $126.9 million in debt and...
5 months ago
Impel Neuropharma rebrands to Impel Pharmaceuticals
Drug Delivery Business
Impel NeuroPharma announced today that it changed its name to Impel Pharmaceuticals as part of a corporate rebrand.
25 months ago
Impel NeuroPharma Announces Key Management Team Appointments As Company Advances Toward ...
PR Newswire
PRNewswire/ -- Impel NeuroPharma, a late-stage pharmaceutical company focused on utilizing our proprietary technology to develop and...
38 months ago
Press Releases
3M News Center
3M signs strategic agreements with Impel to accelerate commercialization and cost effectiveness of POD technology platform and Impel's...
103 months ago
Impel Neuropharma Announces Company Will Now Be Known as Impel Pharmaceuticals to Reflect Corporate ...
GlobeNewswire
SEATTLE, April 25, 2022 (GLOBE NEWSWIRE) -- Impel NeuroPharma (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing...
25 months ago
Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams' Role Expanded To Chairman And CEO
PR Newswire
PRNewswire/ -- Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative...
48 months ago
Impel's migraine nasal spray affirmed in new data
BioWorld MedTech
Impel Neuropharma Inc. presented multiple abstracts affirming the effectiveness of Trudhesa (dihydroergotamine mesylate) nasal spray in...
25 months ago
Impel NeuroPharma leases hard-to-find lab space – and there's room for more startups - Puget Sound Business Journal
The Business Journals
BioMed Realty designed the combined lab and office suites for biotech companies entering the next stage of growth.
81 months ago